Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)
India flag India · Delayed Price · Currency is INR
36.98
-0.90 (-2.38%)
At close: Feb 12, 2026

BOM:524396 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Revenue
425.2334.02400.35300.35223.82357.5
Other Revenue
30.31.83.73--0.59
455.49335.82404.09300.35223.82358.1
Revenue Growth (YoY)
44.82%-16.89%34.54%34.19%-37.50%20.30%
Cost of Revenue
403.55310.16376.61274.72195.16324.83
Gross Profit
51.9425.6727.4825.6328.6633.27
Selling, General & Admin
8.877.976.826.347.947.59
Other Operating Expenses
6.626.627.666.666.11.94
Operating Expenses
18.6218.3818.4717.2918.3213.64
Operating Income
33.327.2998.3410.3419.63
Interest Expense
-0.26-0.36-0.4-0.42-0.39-0.64
Interest & Investment Income
0.440.440.070.020.210.21
Other Non Operating Income (Expenses)
-0.01-0.01-0.02-0.01-0.02-0.04
EBT Excluding Unusual Items
33.497.368.657.9310.1519.16
Gain (Loss) on Sale of Assets
-----0.03
Pretax Income
33.497.368.657.9310.1519.19
Income Tax Expense
4.911.781.562.333.176.78
Net Income
28.595.587.095.66.9812.41
Net Income to Common
28.595.587.095.66.9812.41
Net Income Growth
433.40%-21.36%26.55%-19.76%-43.74%2.83%
Shares Outstanding (Basic)
161616161616
Shares Outstanding (Diluted)
161616161616
Shares Change (YoY)
-0.07%-----0.00%
EPS (Basic)
1.750.340.440.340.430.76
EPS (Diluted)
1.750.340.440.340.430.76
EPS Growth
432.96%-21.98%28.17%-20.77%-43.74%3.08%
Free Cash Flow
-36-20.2423.71-1.22-2.95.44
Free Cash Flow Per Share
-2.20-1.241.46-0.07-0.180.33
Gross Margin
11.40%7.64%6.80%8.53%12.80%9.29%
Operating Margin
7.31%2.17%2.23%2.78%4.62%5.48%
Profit Margin
6.28%1.66%1.75%1.87%3.12%3.47%
Free Cash Flow Margin
-7.90%-6.03%5.87%-0.41%-1.29%1.52%
EBITDA
36.4611.081312.6314.6223.75
EBITDA Margin
8.00%3.30%3.22%4.21%6.53%6.63%
D&A For EBITDA
3.143.83.994.294.284.12
EBIT
33.327.2998.3410.3419.63
EBIT Margin
7.31%2.17%2.23%2.78%4.62%5.48%
Effective Tax Rate
14.65%24.23%18.04%29.33%31.19%35.31%
Revenue as Reported
456.75337.07405.25301.32225.33365.5
Advertising Expenses
-0.120.120.10.070.07
Source: S&P Global Market Intelligence. Standard template. Financial Sources.